BARBARA CELEIRO: Open Payments
NPI 1346200797 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 33 payments from 8 companies in 2025. Trend: 2023 $603 · 2024 $383 · 2025 $584
Food & beverage: $584
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $156 |
| Amgen Inc. | 10 | $135 |
| Lilly USA, LLC | 5 | $87 |
| Exact Sciences Corporation | 4 | $85 |
| Abbott Laboratories | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: OTEZLA, MOUNJARO, The Cologuard Plus Collection Kit, REPATHA, FREESTYLE LIBRE 3, Ozempic, LEQVIO, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
